Genetics and Functional Imaging: Effects of APOE, BDNF, COMT, and KIBRA in Aging

Neuropsychology Review

Volumn 25, Issue 1, 2015, Pages 47-62

  Papenberg, Goran ^a,b   Salami, Alireza ^a,c   Persson, Jonas ^a   Lindenberger, Ulman ^b,d   Bäckman, Lars ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b MAX PLANCK INSTITUTE FOR HUMAN DEVELOPMENT   (Germany)

^c UMEÅ UNIVERSITY   (Sweden)

^d MAX PLANCK UCL CENTRE FOR COMPUTATIONAL PSYCHIATRY AND AGEING RESEARCH   (United Kingdom)

Author keywords

Aging; APOE; BDNF; Cognition; COMT; Functional brain imaging; Genetics; KIBRA

Indexed keywords

APOLIPOPROTEIN E; BRAIN DERIVED NEUROTROPHIC FACTOR; CATECHOL METHYLTRANSFERASE; COMT PROTEIN, HUMAN; PHOSPHOPROTEIN; SIGNAL PEPTIDE; WWC1 PROTEIN, HUMAN;

AGING; BRAIN; FEMALE; GENETIC VARIABILITY; GENETICS; HEMISPHERIC DOMINANCE; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSIOLOGY; VASCULARIZATION;

AGING; APOLIPOPROTEINS E; BRAIN; BRAIN-DERIVED NEUROTROPHIC FACTOR; CATECHOL O-METHYLTRANSFERASE; FEMALE; FUNCTIONAL LATERALITY; GENETIC VARIATION; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MAGNETIC RESONANCE IMAGING; MALE; PHOSPHOPROTEINS;

EID: 84939989914     PISSN: 10407308     EISSN: 15736660     Source Type: Journal    
DOI: 10.1007/s11065-015-9279-8     Document Type: Review

References (146)

1. Adamson, M. M., Benjamin Hutchinson, J., Shelton, A., Wagner, A. D., & Taylor, J. L. (2011). Reduced hippocampal activity during encoding in cognitively normal adults carrying the APOE ε4 allele. Neuropsychologia, 49(9), 2448–2455. doi:10.1016/j.neuropsychologia.2011.04.022.
2. Almeida, O. P., Schwab, S. G., Lautenschlager, N. T., Morar, B., Greenop, K. R., Flicker, L., & Wildenauer, D. (2008). KIBRA genetic polymorphism influences episodic memory in later life, but does not increase the risk of mild cognitive impairment. Journal of Cellular and Molecular Medicine, 12(5A), 1672–1676. doi:10.1111/j.1582-4934.2008.00229.x.
3. Bäckman, L., Jones, S., Small, B. J., Agüero-Torres, H., & Fratiglioni, L. (2003). Rate of cognitive decline in preclinical Alzheimer’s disease: the role of comorbidity. Journals of Gerontology. Series B, Psychological, 58, 228–236. doi:10.1093/geronb/58.4.P228.
4. Bäckman, L., Nyberg, L., Lindenberger, U., Li, S.-C., & Farde, L. (2006). The correlative triad among aging, dopamine, and cognition: current status and future prospects. Neuroscience and Biobehavioral Reviews, 30(6), 791–807. doi:10.1016/j.neubiorev.2006.06.005.
5. Bäckman, L., Lindenberger, U., Li, S.-C., & Nyberg, L. (2010). Linking cognitive aging to alterations in dopamine neurotransmitter functioning: recent data and future avenues. Neuroscience & Biobehavioral Reviews, 34(5), 670–677. doi:10.1016/j.neubiorev.2006.06.005.
6. Banner, H., Bhat, V., Etchamendy, N., Joober, R., & Bohbot, V. D. (2011). The brain-derived neurotrophic factor Val66Met polymorphism is associated with reduced functional magnetic resonance imaging activity in the hippocampus and increased use of caudate nucleus-dependent strategies in a human virtual navigation task. European Journal of Neuroscience, 33(5), 968–977. doi:10.1111/j.1460-9568.2010.07550.x.
7. Barnett, J. H., Jones, P. B., Robbins, T. W., & Müller, U. (2007). Effects of the catechol-O-methyltransferase Val158Met polymorphism on executive function: a meta-analysis of the Wisconsin Card Sort Test in schizophrenia and healthy controls. Molecular Psychiatry, 12(5), 502–509.
8. Barnett, J. H., Scoriels, L., & Munafò, M. R. (2008). Meta-analysis of the cognitive effects of the catechol-O-methyltransferase gene Val158/108Met polymorphism. Biological Psychiatry, 64(2), 137–144. doi:10.1016/j.biopsych.2008.01.005.
9. Bassett, S. S., Yousem, D. M., Cristinzio, C., Kusevic, I., Yassa, M. A., Caffo, B. S., & Zeger, S. L. (2006). Familial risk for Alzheimer’s disease alters fMRI activation patterns. Brain: A Journal of Neurology, 129(Pt 5), 1229–1239. doi:10.1093/brain/awl089.
10. Binder, D. K., & Scharfman, H. E. (2004). Brain-derived neurotrophic factor. Growth Factors, 22(3), 123–131. doi:10.1080/08977190410001723308.
11. Blacker, D., Haines, J. L., Rodes, L., Terwedow, H., Go, R., Harrell, L. E., & Tanzi, R. E. (1997). ApoE-4 and age at onset of Alzheimer’s disease: the NIMH genetics initiative. Neurology, 48, 139–147. doi:10.1212/WNL.48.1.139.
12. Blanchard, M. M., Chamberlain, S. R., Roiser, J., Robbins, T. W., & Müller, U. (2011). Effects of two dopamine-modulating genes (DAT1 9/10 and COMT Val/Met) on n-back working memory performance in healthy volunteers. Psychological Medicine, 41(3), 611–618. doi:10.1017/S003329171000098X.
13. Bolton, J. L., Marioni, R. E., Deary, I. J., Harris, S. E., Stewart, M. C., Murray, G. D., & Price, J. F. (2010). Association between polymorphisms of the dopamine receptor D2 and catechol-o-methyl transferase genes and cognitive function. Behavioral Genetics, 40(5), 630–638. doi:10.1007/s10519-010-9372-y.
14. Bondi, M. W., Houston, W. S., Eyler, L. T., & Brown, G. G. (2005). fMRI evidence of compensatory mechanisms in older adults at genetic risk for Alzheimer disease. Neurology, 64(3), 501–508. doi:10.1212/01.WNL.0000150885.00929.7E.
15. Bookheimer, S. Y., Strojwas, M. H., Cohen, M. S., Saunders, A. M., Pericak-Vance, M. A., Mazziotta, J. C., & Small, G. W. (2000). Patterns of brain activation in people at risk for Alzheimer’s disease. New England Journal of Medicine, 343(7), 450–456. doi:10.1056/NEJM200008173430701.
16. Boyle, P. A., Buchman, A. S., Wilson, R. S., Kelly, J. F., & Bennett, D. A. (2010). The APOE ε4 allele is associated with incident mild cognitive impairment among community-dwelling older persons. Neuroepidemiology, 34(1), 43–49. doi:10.1159/000256662.
17. Bretsky, P., Guralnik, J. M., Launer, L., Albert, M., & Seeman, T. E. (2003). The role of APOE- 4 in longitudinal cognitive decline: MacArthur Studies of Successful Aging. Neurology, 60(7), 1077–1081. doi:10.1212/01.wnl.0000055875.26908.24.
18. Buckner, R. L., Snyder, A. Z., Shannon, B. J., LaRossa, G., Sachs, R., Fotenos, A. F., & Mintun, M. A. (2005). Molecular, structural, and functional characterization of Alzheimer’s disease: evidence for a relationship between default activity, amyloid, and memory. Journal of Neuroscience, 25(34), 7709–7717. doi:10.1523/JNEUROSCI.2177-05.2005.
19. Buckner, R. L., Andrews-Hanna, J. R., & Schacter, D. L. (2008). The brain’s default network: anatomy, function, and relevance to disease. Annals of the New York Academy of Sciences, 1124, 1–38. doi:10.1196/annals.1440.011.
20. Bunce, D., Fratiglioni, L., Small, B. J., Winblad, B., & Bäckman, L. (2004). APOE and cognitive decline in preclinical Alzheimer’s disease and non-demented aging. Neurology, 63, 816–821. doi:10.1212/01.WNL.0000137041.86153.42.
21. Burzynska, A. Z., Nagel, I. E., Preuschhof, C., Li, S. C., Lindenberger, U., Backman, L., & Heekeren, H. R. (2011). Microstructure of frontoparietal connections predicts cortical responsivity and working memory performance. Cerebral Cortex, 21(10), 2261–2271. doi:10.1093/cercor/bhq293.
22. Cappell, K. A., Gmeindl, L., & Reuter-Lorenz, P. A. (2006). Age differences in DLPFC recruitment during verbal working memory maintenance depend on memory load. Paper presented at the Society for Neuroscience, Atlanta, GA.
23. Ceaser, A., Csernansky, J. G., & Barch, D. M. (2013). COMT influences on prefrontal and striatal blood oxygenation level-dependent responses during working memory among individuals with schizophrenia, their siblings, and healthy controls. Cognitive Neuropsychiatry, 18(4), 257–283. doi:10.1080/13546805.2012.698100.
24. Cohen, R. M., Small, C., Lalonde, F., Friz, J., & Sunderland, T. (2001). Effect of apolipoprotein E genotype on hippocampal volume loss in aging healthy women. Neurology, 57, 2223–e2228. doi:10.1212/WNL.57.12.2223.
25. Corder E. H., Saunders A. M., Strittmatter W. J., Schmechel D. E., Gaskell P. C., Rimmler J. B., … Haines J. L. (1995). Apolipoprotein E, survival in Alzheimer’s disease patients, and the competing risks of death and Alzheimer’s disease. Neurology, 45, 1323–1328. doi:10.1212/WNL.45.7.1323.
26. Crivello, F., Lemaitre, H., Dufouil, C., Grassiot, B., Delcroix, N., Tzourio-Mazoyer, N., Tzourio, C., & Mazoyer, B. (2010). Effects of ApoE-epsilon4 allele load and age on the rates of grey matter and hippocampal volumes loss in a longitudinal cohort of 1186 healthy elderly persons. NeuroImage, 53, 1064–e1069. doi:10.1016/j.neuroimage.2009.
27. Das, D., Tan, X., Bielak, A. A., Cherbuin, N., Easteal, S., & Anstey, K. J. (2014). Cognitive ability, intraindividual variability, and common genetic variants of catechol-O-methyltransferase and brain-derived neurotrophic factor: a longitudinal study in a population-based sample of older adults. Psychology and Aging, 29(2), 393–403. doi:10.1037/a0035702.
28. de Frias, C. M., Annerbrink, K., Westberg, L., Eriksson, E., Adolfsson, R., & Nilsson, L. G. (2005). Catechol O-methyltransferase Val158Met polymorphism is associated with cognitive performance in nondemented adults. Journal of Cognitive Neuroscience, 17(7), 1018–1025. doi:10.1162/0898929054475136.
29. de Frias, C. M., Lövdén, M., Lindenberger, U., & Nilsson, L.-G. (2007). Revisiting the dedifferentiation hypothesis with longitudinal multi-cohort data. Intelligence, 35(4), 381–392. doi:10.1016/j.intell.2006.07.011.
30. Deary, I. J., Spinath, F. M., & Bates, T. C. (2006). Genetics of intelligence. European Journal of Human Genetics, 14, 690–700. doi:10.1038/sj.ejhg.5201588.
31. Deary, I. J., Penke, L., & Johnson, W. (2010). The neuroscience of human intelligence differences. Nature Review Neuroscience, 11(3), 201–211. doi:10.1038/nrn2793.
32. Dennis, N. A., Browndyke, J. N., Stokes, J., Need, A., Burke, J. R., Welsh-Bohmer, K. A., & Cabeza, R. (2010). Temporal lobe functional activity and connectivity in young adult APOE varepsilon4 carriers. Alzheimers Dement, 6, 303–311. doi:10.1016/j.jalz.2009.07.003.
33. Dickie, E. W., Tahmasebi, A., French, L., Kovacevic, N., Banaschewski, T., Barker, G. J., …, & Paus, T. (2014). Global genetic variations predict brain response to faces. PLoS Genet, 10(8), e1004523. doi:10.1371/journal.pgen.1004523.
34. Dik, M. G., Deeg, D. J. H., Bouter, L. M., Corder, E. H., Kok, A., & Jonker, C. (2000). Stroke and Apolipoprotein E 4 are independent risk factors for cognitive decline: a population-based study. Stroke, 31(10), 2431–2436. doi:10.1161/01.str.31.10.2431.
35. Dodds, C. M., Henson, R. N., Suckling, J., Miskowiak, K. W., Ooi, C. Tait, R., …, Nathan, P. J. (2013). Effects of the BDNF Val66Met polymorphism and met allele load on declarative memory related neural networks. PLoS One, 8(11), e74133. doi:10.1371/journal.pone.0074133.eCollection2013.
36. Donix, M., Small, G. W., & Bookheimer, S. Y. (2012). Family history and APOE-4 genetic risk in Alzheimer’s Disease. Neuropsychology Review, 60(1), 298–309. doi:10.1007/s11065-012-9193-2.
37. Ebner, N. C., Maura, G. M., Macdonald, K., Westberg, L., & Fischer, H. (2013). Oxytocin and socioemotional aging: current knowledge and future trends. Frontiers in Human Neuroscience, 7, 487. doi:10.3389/fnhum.2013.00487.
38. 108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proceedings of the National Academy of Sciences in the U S A, 98(12), 6917–6922. doi:10.1073/pnas.111134598.
39. Egan, M. F., Kojima, M., Callicott, J. H., Goldberg, T. E., Kolachana, B. S., Bertolino, A.,.. Weinberger, D. R. (2003). The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell, 112(2), 257–269. doi:10.1016/S0092-8674(03)00035-7.
40. Erickson, K. I., Banducci, S. E., Weinstein, A. M., Macdonald, A. W., Ferrell, R. E., Halder, I., & Manuck, S. B. (2013). The brain-derived neurotrophic factor Val66Met polymorphism moderates an effect of physical activity on working memory performance. Psychological Science, 24, 1770–1779. doi:10.1177/0956797613480367.
41. Farrer, L. A., Cupples, L. A., Haines, J. L., Hyman, B., Kukull, W. A., Mayeux, R., & Van Duijn, C. M. (1997). Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. JAMA, 278, 1349–1356. doi:10.1001/jama.1997.03550160069041.
42. Ferencz, B., Laukka, E. J., Welmer, A. K., Kalpouzos, G., Angleman, S., … Bäckman, L. (2014). The benefits of staying active in old age: physical activity counteracts the negative influence of PICALM, BIN1, and CLU risk alleles on episodic memory functioning. Psychology Aging, 29(2), 440–449. doi:10.1037/a0035465.
43. Filippini, N., MacIntosh, B. J., Hough, M. G., Goodwin, G. M., Frisoni, G. B., Smith, S. M., Matthews, P. M., Beckmann, C. F., & Mackay, C. E. (2009). Distinct patterns of brain activity in young carriers of the APOE-epsilon4 allele. Proceedings of the National Academy of Sciences of the United States of America, 106, 7209–7214. doi:10.1016/j.neuroimage.2010.08.009.
44. Filippini, N., Ebmeier, K. P., MacIntosh, B. J., Trachtenberg, A. J., Frisoni, G. B., Wilcock, G. K., & Mackay, C. E. (2011). Differential effects of the APOE genotype on brain function across the lifespan. NeuroImage, 54(1), 602–610. doi:10.1016/j.neuroimage.2010.08.009.
45. Finkel, D., Reynolds, C. A., McArdle, J. J., & Pedersen, N. L. (2005). The longitudinal relationship between processing speed and cognitive ability: genetic and environmental influences. Behavior Genetics, 35, 535–549. doi:10.1007/s10519-005-3281-5.
46. Fleisher, A. S., Houston, W. S., Eyler, L. T., Frye, S., Jenkins, C., Thal, L. J., & Bondi, M. W. (2005). Identification of Alzheimer disease risk by functional magnetic resonance imaging. Archives of Neurology, 62, 1881–1888. doi:10.1001/archneur.62.12.1881.
47. Fleisher, A. S., Podraza, K. M., Bangen, K. J., Taylor, C., Sherzai, A., Sidhar, K., & Buxton, R. B. (2009a). Cerebral perfusion and oxygenation differences in Alzheimer’s disease risk. Neurobiology of Aging, 30(11), 1737–1748. doi:10.1016/j.neurobiolaging.2008.01.012.
48. Fleisher, A. S., Sherzai, A., Taylor, C., Langbaum, J. B., Chen, K., & Buxton, R. B. (2009b). Resting-state BOLD networks versus task-associated functional MRI for distinguishing Alzheimer’s disease risk groups. NeuroImage, 47(4), 1678–1690. doi:10.1016/j.neuroimage.2009.06.021.
49. Getz, G. S., & Reardon, C. A. (2009). Apoprotein E as a lipid transport and signaling protein in the blood, liver, and artery wall. Journal of Lipid Research, 50(Suppl), S156–S161. doi:10.1194/jlr. R800058-JLR200.
50. Ghisletta, P., Bäckman, L., Bertram, L., Brandmaier, A. M., Gerstorf, D., Liu, T., & Lindenberger, U. (2014). The Val/Met polymorphism of the brain-derived neurotrophic factor (BDNF) gene predicts decline in perceptual speed in older adults. Psychology and Aging, 29(2), 384–392. doi:10.1037/a0035201.
51. Grady, C. (2012). The cognitive neuroscience of ageing. Nature Review Neuroscience, 13(7), 491–505. doi:10.1038/nrn3256.
52. Green, A. E., Munafo, M. R., DeYoung, C. G., Fossella, J. A., Fan, J., & Gray, J. R. (2008). Using genetic data in cognitive neuroscience: from growing pains to genuine insights. Nature Review Neuroscience, 9(9), 710–720. doi:10.1038/nrn2461.
53. Greenwood, P. M., Lin, M. K., Sundararajan, R., Fryxell, K. J., & Parasuraman, R. (2014). Healthy aging increases the cognitive effects of two genes that influence extracellular dopamine. Psychology and Aging, 29(2), 363–373. doi:10.1037/a0036109.
54. Growdon, J. H., Locascio, J. J., Corlin, S., Gomezsla, T., & Hyman, B. T. (1996). Apolipoprotein E genotype does not influence rates of cognitive decline in Alzheimer’s disease. Neurology, 47, 444–448. doi:10.1212/WNL.47.2.444.
55. Han, S. D., Houston, W. S., Jak, A. J., Eyler, L. T., Nagel, B. J., Fleisher, A. S., & Bondi, M. W. (2007). Verbal paired-associate learning by APOE genotype in non-demented older adults: fMRI evidence of a right hemispheric compensatory response. Neurobiology of Aging, 28(2), 238–247. doi:10.1016/j.neurobiolaging.2005.12.013.
56. Hariri, A. R., Goldberg, T. E., Mattay, V. S., Kolachana, B. S., Callicott, J. H., Egan, M. F., & Weinberger, D. R. (2003). Brain-derived neurotrophic factor val66met polymorphism affects human memory-related hippocampal activity and predicts memory performance. Journal of Neuroscience, 23(17), 6690–6694. doi:23/17/6690.
57. Harris, S. E., & Deary, I. J. (2011). The genetics of cognitive ability and cognitive ageing in healthy older people. Trends in Cognitive Science, 15(9), 388–394. doi:10.1016/j.tics.2011.07.004.
58. Hashimoto, R., Moriguchi, Y., Yamashita, F., Mori, T., Nemoto, K., Okada, T., & Ohnishi, T. (2008). Dose-dependent effect of the Val66Met polymorphism of the brain-derived neurotrophic factor gene on memory-related hippocampal activity. Neuroscience Research, 61(4), 360–367. doi:10.1016/j.neures.2008.04.003.
59. Heise, V., Filippini, N., Ebmeier, K. B., & Mackay, C. E. (2012). The APOE ε4 allele modulates brain white matter integrity in healthy adults. Molecular Psychiatry, 16, 908–916. doi:10.1038/mp.2010.90.
60. Ihle, A., Bunce, D., & Kliegel, M. (2012). APOE ε4 and cognitive function in early life: a meta-analysis. Neuropsychology, 23(3), 267–277. doi:10.1037/a0026769.
61. Ikeda, O., Murakami, M., Ino, H., Yamazaki, M., Koda, M., Nakayama, C., & Moriya, H. (2002). Effects of brain-derived neurotrophic factor (BDNF) on compression-induced spinal cord injury: BDNF attenuates down-regulation of superoxide dismutase expression and promotes up-regulation of myelin basic protein expression. Journal of Neuropathology and Experimental Neurology, 61(2), 142–153.
62. Johnson, S. C., Schmitz, T. W., Trivedi, M. A., Ries, M. L., Torgerson, B. M., Carlsson, C. M., & Sager, M. A. (2006). The influence of Alzheimer disease family history and apolipoprotein E epsilon4 on mesial temporal lobe activation. Journal of Neuroscience, 26(22), 6069–6076. doi:10.1523/JNEUROSCI.0959-06.2006.
63. Jonsson, E. G., Nothen, M. M., Grunhage, F., Farde, L., Nakashima, Y., Propping, P., & Sedvall, G. C. (1999). Polymorphisms in the dopamine D2 receptor gene and their relationships to striatal dopamine receptor density of healthy volunteers. Molecular Psychiatry, 4(3), 290–296. doi:10.1038/sj.mp.4000532.
64. Josefsson, M., de Luna, X., Pudas, S., Nilsson, L. G., & Nyberg, L. (2012). Genetic and lifestyle predictors of 15-year longitudinal change in episodic memory. Journal of the American Geriatrics Society, 60(12), 2308–2312. doi:10.1111/jgs.12000.
65. Kambeitz, J. P., Bhattacharyya, S., Kambeitz-Ilankovic, L. M., Valli, I., Collier, D. A., & McGuire, P. (2012). Effect of BDNF val(66)met polymorphism on declarative memory and its neural substrate: a meta-analysis. Neuroscience and Biobehavioral Reviews, 36(9), 2165–2177. doi:10.1016/j.neubiorev.2012.07.002.
66. Kauppi, K., Nilsson, L. G., Adolfsson, R., Eriksson, E., & Nyberg, L. (2011). KIBRA polymorphism is related to enhanced memory and elevated hippocampal processing. Journal of Neuroscience, 31(40), 14218–14222. doi:10.1523/JNEUROSCI.3292-11.2011.
67. Kauppi, K., Nilsson, L. G., Persson, J., & Nyberg, L. (2014). Additive genetic effect of APOE and BDNF on hippocampus activity. NeuroImage, 89, 306–313. doi:10.1016/j.neuroimage.2013.11.049.
68. Kennedy, K. M., Rodrigue, K. M., Land, S. J., & Raz, N. (2009). BDNF Val66Met polymorphism influences age differences in microstructure of the Corpus Callosum. Frontiers in Human Neuroscience, 3, 19. doi:10.3389/neuro.09.019.2009.
69. Klostermann, E. C., Braskie, M. N., Landau, S. M., O’Neil, J. P., & Jagust, W. J. (2012). Dopamine and frontostriatal networks in cognitive aging. Neurobiology of Aging, 33(3), e15–e24. doi:10.1016/j.neurobiolaging.2011.03.002.
70. Laukka, E. J., Lövdén, M., Herlitz, A., Karlsson, S., Ferencz, B., Pantzar, A., & Bäckman, L. (2013). Genetic effects on old-age cognitive functioning: a population-based study. Psychology and Aging, 28(1), 262–274. doi:10.1037/a0030829.
71. Li, S.-C., Chicherio, C., Nyberg, L., von Oertzen, T., Nagel, I. E., Papenberg, G., & Backman, L. (2010). Ebbinghaus revisited: influences of the BDNF Val66Met polymorphism on backward serial recall are modulated by human aging. Journal of Cognitive Neuroscience, 22(10), 2164–2173. doi:10.1162/jocn.2009.21374.
72. Li, S.-C., Papenberg, G., Nagel, I. E., Preuschhof, C., Schroder, J., Nietfeld, W.,.. Backman, L. (2012). Aging magnifies the effects of dopamine transporter and D2 receptor genes on backward serial memory. Neurobiology Aging. doi:10.1016/j.neurobiolaging.2012.08.001.
73. Lim, Y. Y., Villemagne, V. L., Laws, S. M., Ames, D., Pietrzak, R. H., Ellis, K. A.,.. Group, Aibl Research. (2014). Effect of BDNF Val66Met on memory decline and hippocampal atrophy in prodromal Alzheimer’s disease: a preliminary study. PLoS One, 9(1), e86498. doi:10.1371/journal.pone.0086498.
74. Lind, J., Persson, J., Ingvar, M., Larsson, A., Cruts, M., Van Broeckhoven, C.,.. Nyberg, L. (2006). Reduced functional brain activity response in cognitively intact apolipoprotein E epsilon4 carriers. Brain: A Journal Of Neurology, 129(Pt 5), 1240–1248. doi:10.1093/brain/awl054.
75. Lindenberger, U., & Ghisletta, P. (2009). Cognitive and sensory declines in old age: gauging the evidence for a common cause. Psychology and Aging, 24(1), 1–16. doi:10.1037/a0014986.
76. Lindenberger, U., Nagel, I. E., Chicherio, C., Li, S. C., Heekeren, H. R., & Bäckman, L. (2008). Age-related decline in brain resources modulates genetic effects on cognitive functioning. Frontiers in Neuroscience, 2(2), 234–244. doi:10.3389/neuro.01.039.2008.
77. Lindenberger, U., Burzynska, A. Z., & Nagel, I. E. (2013). Heterogeneity in frontal lobe aging. In D. T. Stuss & R. T. Knight (Eds.), Principles of frontal lobe functions (Vol. 2nd. ed.). New York: Oxford University Press.
78. Liu, F., Pardo, L. M., Schuur, M., Sanchez-Juan, P., Isaacs, A., Sleegers, K., & van Duijn, C. M. (2010). The apolipoprotein E gene and its age-specific effects on cognitive function. Neurobiology of Aging, 31(10), 1831–1833. doi:10.1016/j.neurobiolaging.2008.09.015.
79. Liu, C. C., Kanekiyo, T., Xu, H., & Bu, G. (2013). Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy. Nature Reviews Neurology, 9(2), 106–118. doi:10.1038/nrneurol.2012.263.
80. Lotta, T., Vidgren, J., Tilgmann, C., Ulmanen, I., Melen, K., Julkunen, I., & Taskinen, J. (1995). Kinetics of human soluble and membrane-bound catechol O-methyltransferase: a revised mechanism and description of the thermolabile variant of the enzyme. Biochemistry, 34(13), 4202–4210. doi:10.1021/bi00013a008.
81. Lu, B. (2003). BDNF and activity-dependent synaptic modulation. Learning and Memory, 10(2), 86–98. doi:10.1101/lm.54603.
82. Mahley, R. W., Weisgraber, K. H., & Huang, Y. (2009). Apolipoprotein E: structure determines function, from atherosclerosis to Alzheimer’s disease to AIDS. Journal of Lipid Research, 50(Suppl), S183–S188. doi:10.1194/jlr.R800069-JLR200.
83. Matsumoto, M., Weickert, C. S., Akil, M., Lipska, B. K., Hyde, T. M., Herman, M. M.,.. Weinberger, D. R. (2003). Catechol O-methyltransferase mRNA expression in human and rat brain: evidence for a role in cortical neuronal function. Neuroscience, 116(1), 127–137. doi:10.1016/S0306-4522(02)00556-0.
84. Mier, D., Kirsch, P., & Meyer-Lindenberg, A. (2010). Neural substrates of pleiotropic action of genetic variation in COMT: a meta-analysis. Molecular Psychiatry, 15(9), 918–927. doi:10.1038/mp.2009.36.
85. Milnik, A., Heck, A., Vogler, C., Heinze, H. J., de Quervain, D. J., & Papassotiropoulos, A. (2012). Association of KIBRA with episodic and working memory: a meta-analysis. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 159B(8), 958–969. doi:10.1002/ajmg.b.32101.
86. Miyajima, F., Ollier, W., Mayes, A., Jackson, A., Thacker, N., Rabbitt, P., & Payton, A. (2008). Brain-derived neurotrophic factor polymorphism Val66Met influences cognitive abilities in the elderly. Genes, Brain and Behavior, 7(4), 411–417. doi:10.1111/j.1601-183X.2007.00363.x.
87. Modrego, P. J. (2006). Predictors of conversion to dementia of probable Alzheimer type in patients with mild cognitive impairment. Current Alzheimer Research, 3(2), 161–170. doi:10.2174/156720506776383103.
88. Mondadori, C. R., de Quervain, D. J., Buchmann, A., Mustovic, H., Wollmer, M. A., Schmidt, C. F., Boesiger, P., Hock, C., Nitsch, R. M., Papassotiropoulos, A., & Henke, K. (2007). Better memory and neural efficiency in young apolipoprotein E epsilon4 carriers. Cerebral Cortex, 17, 1934–1947. doi:10.1093/cercor/bhl103.
89. Monteggia, L. M., Barrot, M., Powell, C., Berton, O., Galanis, V., Nagy, A., …, & Nestler, E. J. (2004) Essential role of BDNF in adult hippocampal function and depression. Proceedings of the National Academy of Sciences, 101(29), 10827–10832. doi:10.1073/pnas.0402141101.
90. Moretti, D. V., Prestia, A., Fracassi, C., Binetti, G., Zanetti, O., & Frisoni, G. B. (2012). Specific EEG changes associated with atrophy of hippocampus in subjects with mild cognitive impairment and Alzheimer’s disease. International Journal of Alzheimer’s Disease, 2012, 253153. doi:10.1155/2012/253153.
91. Morse, J. K., Wiegand, S. J., Anderson, K., You, Y., Cai, N., Carnahan, J.,.. et al. (1993). Brain-derived neurotrophic factor (BDNF) prevents the degeneration of medial septal cholinergic neurons following fimbria transection. Journal of Neuroscience, 13(10), 4146–4156.
92. Muse, J., Emery, M., Sambataro, F., Lemaitre, H., Tan, H. Y., Chen, Q.,.. Mattay, V. S. (2014). WWC1 genotype modulates age-related decline in episodic memory function across the adult life span. Biology Psychiatry, 75(9), 693–700. doi:10.1016/j.biopsych.2013.09.036.
93. Nagel, I. E., Chicherio, C., Li, S.-C., von Oertzen, T., Sander, T., Villringer, A.,.. Lindenberger, U. (2008). Human aging magnifies genetic effects on executive functioning and working memory. Frontiers in Human Neuroscience, 2, 1. doi:10.3389/neuro.09.001.2008.
94. Nagel, I. E., Preuschhof, C., Li, S. C., Nyberg, L., Bäckman, L., Lindenberger, U., & Heekeren, H. R. (2009). Performance level modulates adult age differences in brain activation during spatial working memory. Proceedings of the National Academy of Sciences in the U S A, 106(52), 22552–22557. doi:10.1073/pnas.0908238106.
95. Nichols, L. M., Masdeu, J. C., Mattay, V. S., Kohn, P., Emery, M., Sambataro, F., …, Berman, K. F. (2012). Interactive effect of apolipoprotein e genotype and age on hippocampal activation during memory processing in healthy adults. Archives of General Psychiatry, 69(8), 804–13. doi:10.1001/archgenpsychiatry.2011.1893.
96. Nyberg, L., & Salami, A. (2014). The APOE ε4 allele in relation to brain white-matter microstructure in adulthood and aging. Scandinavian Journal of Psychology, 55, 263–267. doi:10.1111/sjop.12099.
97. Nyberg, L., Lövdén, M., Riklund, K., Lindenberger, U., & Bäckman, L. (2012). Memory aging and brain maintenance. Trends in Cognitive Science, 16(5), 292–305. doi:10.1016/j.tics.2012.04.005.
98. Nyberg, L., Andersson, M., Kauppi, K., Lundquist, A., Persson, J., Pudas, S., & Nilsson, L. G. (2014). Age-related and genetic modulation of frontal cortex efficiency. Journal of Cognitive Neuroscience, 26(4), 746–754. doi:10.1162/jocn_a_00521.
99. O’Brien, J. L., O’Keefe, K. M., LaViolette, P. S., DeLuca, A. N., Blacker, D., Dickerson, B. C., & Sperling, R. A. (2010). Longitudinal fMRI in elderly reveals loss of hippocampal activation with clinical decline. Neurology, 74(24), 1969–1976. doi:10.1212/WNL.0b013e3181e3966e.
100. Okuizumi, K., Onodera, O., Namba, Y., Ikeda, K., Yamamoto, T., Seki, K.,.. Tsuji, S. (1995). Genetic association of the very low density lipoprotein (VLDL) receptor gene with sporadic Alzheimer’s disease. Nature Genetic, 11, 207–209. doi:10.1038/ng1095-207.
101. Pantzar, A., Laukka, E. J., Atti, A. R., Papenberg, G., Keller, L., Graff, C.,.. Backman, L. (2014). Interactive effects of KIBRA and CLSTN2 polymorphisms on episodic memory in old-age unipolar depression. Neuropsychologia. doi:10.1016/j.neuropsychologia.2014.07.020.
102. Papassotiropoulos, A., Stephan, D. A., Huentelman, M. J., Hoerndli, F. J., Craig, D. W., Pearson, J. V.,.. de Quervain, D. J. (2006). Common Kibra alleles are associated with human memory performance. Science, 314(5798), 475–478. doi:10.1126/science.1129837.
103. Papenberg, G., Backman, L., Nagel, I. E., Nietfeld, W., Schroder, J., Bertram, L.,.. Li, S. C. (2013). COMT polymorphism and memory dedifferentiation in old age. Psychology Aging. doi:10.1037/a0033225.
104. Papenberg, G., Li, S. C., Nagel, I. E., Nietfeld, W., Schjeide, B. M., Schroder, J.,.. Backman, L. (2014a). Dopamine and glutamate receptor genes interactively influence episodic memory in old age. Neurobiology Aging, 35(5), 1213 e1213-1218. doi:10.1016/j.neurobiolaging.2013.11.014.
105. Papenberg, G., Lövdén, M., Laukka, E. J., Kalpouzos, G., Keller, L., Graff, C.,.. Bäckman, L. (2014b). Magnified effects of the COMT gene on white-matter microstructure in very old age. Brain Structure & Function. doi:10.1007/s00429-014-0835-4.
106. Persson, J., Rieckmann, A., Kalpouzos, G., Fischer, H., & Bäckman, L. (2014). Influences of a DRD2 polymorphism on updating of long-term memory representations and caudate BOLD activity: magnification in aging. Human Brain Mapping. doi:10.1002/hbm.22704.
107. Pihlajamaki, M., K, O’ Keefe, Bertram, L., Tanzi, R. E., Dickerson, B. C., Blacker, D.,.. Sperling, R. A. (2010). Evidence of altered posteromedial cortical FMRI activity in subjects at risk for Alzheimer disease. Alzheimer Disease and Associated Disorders, 24(1), 28–36. doi:10.1097/WAD.0b013e3181a785c9.
108. Ponomareva, N., Andreeva, T., Protasova, M., Shagam, L., Malina, D., Goltsov, A.,.. Rogaev, E. (2013). Age-dependent effect of Alzheimer’s risk variant of CLU on EEG alpha rhythm in non-demented adults. Front Aging Neuroscience, 5, 86. doi:10.3389/fnagi.2013.00086.
109. Raichle, M. E., MacLeod, A. M., Snyder, A. Z., Powers, W. J., Gusnard, D. A., & Shulman, G. L. (2001). A default mode of brain function. Proceedings of the National Academy of Sciences, USA, 98(2), 676–682. doi:10.1073/pnas.98.2.676.
110. Raichlen, D. A, & Alexander, G. E. (2014). Exercise, APOE genotype, and the evolution of the human lifespan. Trends in Neurosciences, 37(5), 247–55. doi:10.1016/j.tins.2014.03.001.
111. Rasch, B., Papassotiropoulos, A., & de Quervain, D. F. (2010). Imaging genetics of cognitive functions: focus on episodic memory. NeuroImage, 53(3), 870–877. doi:10.1016/j.neuroimage.2010.01.001.
112. Raz, N., Lindenberger, U., Rodrigue, K. M., Kennedy, K. M., Head, D., Williamson, A.,.. Acker, J. D. (2005). Regional brain changes in aging healthy adults: general trends, individual differences and modifiers. Cerebral Cortex, 15(11), 1676–1689. doi:10.1093/cercor/bhi044.
113. Raz, N., Lindenberger, U., Ghisletta, P., Rodrigue, K. M., Kennedy, K. M., & Acker, J. D. (2008). Neuroanatomical correlates of fluid intelligence in healthy adults and persons with vascular risk factors. Cerebral Cortex, 18(3), 718–726. doi:10.1093/cercor/bhm108.
114. Ronn, T., Volkov, P., Davegardh, C., Dayeh, T., Hall, E., Olsson, A. H.,.. Ling, C. (2013). A six months exercise intervention influences the genome-wide DNA methylation pattern in human adipose tissue. PLoS Genet, 9(6), e1003572. doi:10.1371/journal.pgen.1003572.
115. Rönnlund, M., Nyberg, L., Bäckman, L., & Nilsson, L. G. (2005). Stability, growth, and decline in adult life span development of declarative memory: cross-sectional and longitudinal data from a population-based study. Psychology and Aging, 20(1), 3–18. doi:10.1037/0882-7974.20.1.3.
116. Sambataro, F., Reed, J. D., Murty, V. P., Das, S., Tan, H. Y., Callicott, J. H.,.. Mattay, V. S. (2009). Catechol-O-methyltransferase valine(158)methionine polymorphism modulates brain networks underlying working memory across adulthood. Biological Psychiatry, 66(6), 540–548. doi:10.1016/j.biopsych.2009.04.014.
117. Sambataro, F., Murty, V. P., Lemaitre, H. S., Reed, J. D., Das, S., Goldberg, T. E.,.. Mattay, V. S. (2010). BDNF modulates normal human hippocampal ageing [corrected]. Molecular Psychiatry, 15(2), 116–118. doi:10.1038/mp.2009.64.
118. Sanchez, M. M., Das, D., Taylor, J. L., Noda, A., Yesavage, J. A., & Salehi, A. (2011). BDNF polymorphism predicts the rate of decline in skilled task performance and hippocampal volume in healthy individuals. Transl Psychiatry, 1, e51. doi:10.1038/tp.2011.47.
119. Sapkota, S., Vergote, D., Westaway, D., Jhamandas, J., & Dixon, R. A. (2014). Synergistic associations of COMT and BDNF with executive function in aging are selective and modified by APOE. Neurobiology of Aging. doi:10.1016/j.neurobiolaging.2014.06.020.
120. Schaie, K. W., Maitland, S. B., Willis, S. L., & Intrieri, R. C. (1998). Longitudinal invariance of adult psychometric ability factor structures across 7 years. Psychology and Aging, 13(1), 8–20. doi:10.1037//0882-7974.13.1.8.
121. Schiepers, O. J., Harris, S. E., Gow, A. J., Pattie, A., Brett, C. E., Starr, J. M., & Deary, I. J. (2012). APOE E4 status predicts age-related cognitive decline in the ninth decade: longitudinal follow-up of the Lothian Birth Cohort 1921. Molecular Psychiatry, 17(3), 315–324. doi:10.1038/mp.2010.137.
122. Schneider, A., Huentelman, M. J., Kremerskothen, J., Duning, K., Spoelgen, R., & Nikolich, K. (2010). KIBRA: a new gateway to learning and memory? Frontiers in Aging Neuroscience, 2, 4. doi:10.3389/neuro.24.004.2010.
123. Schuck, N. W., Doeller, C. F., Schjeide, B. M., Schroder, J., Frensch, P. A., Bertram, L., & Li, S. C. (2013). Aging and KIBRA/WWC1 genotype affect spatial memory processes in a virtual navigation task. Hippocampus, 23(10), 919–930. doi:10.1002/hipo.22148.
124. Schwab, L. C., Luo, V., Clarke, C. L., & Nathan, P. J. (2014). Effects of the KIBRA single nucleotide polymorphism on synaptic plasticity and memory: a review of the literature. Current Neuropharmacology, 12(3), 281–288. doi:10.2174/1570159X11666140104001553.
125. Slifstein, M., Kolachana, B., Simpson, E. H., Tabares, P., Cheng, B., Duvall, M., & Abi-Dargham, A. (2008). COMT genotype predicts cortical-limbic D1 receptor availability measured with [11C]NNC112 and PET. Molecular Psychiatry, 13(8), 821–827. doi:10.1038/mp.2008.19.
126. Small, B. J., Rosnick, C. B., Fratiglioni, L., & Bäckman, L. (2004). Apolipoprotein E and cognitive performance: a meta-analysis. Psychology and Aging, 19(4), 592–600. doi:10.1037/08827974.19.4.592.supp10.1037/0882-.
127. Small, B. J., Rawson, K. S., Walsh, E., Jim, H. S. L., Hughes, T. F., Iser, L., … Jacobsen. P. B. (2011). Catechol-O-methyltransferase genotype modulates cancer treatment-related cognitive deficits in breast cancer survivors. Cancer, 117, 1369–1376. doi:10.1002/cncr.25685.
128. Smith, J. D. (2002). Apolipoproteins and aging: emerging mechanisms. Ageing Research Reviews, 1, 345–365. doi:10.1016/S1568-1637(02)00005-3.
129. Stuart, K., Summers, M. J., Valenzuela, M. J., & Vickers, J. C. (2014). BDNF and COMT polymorphisms have a limited association with episodic memory performance or engagement in complex cognitive activity in healthy older adults. Neurobiology of Aging, 110, 1–7.
130. Sweatt, D. J. (2013). The emerging field of neuroepigenetics. Neuron, 80(3), 624–632. doi:10.1016/j.neuron.2013.10.023.
131. Thorvaldsson, V., Macdonald, S. W., Fratiglioni, L., Winblad, B., Kivipelto, M., Laukka, E. J., & Backman, L. (2011). Onset and rate of cognitive change before dementia diagnosis: findings from two Swedish population-based longitudinal studies. Journal of International Neuropsychological Society, 17(1), 154–162. doi:10.1017/S1355617710001372.
132. Trivedi, M. A., Schmitz, T. W., Ries, M. L., Torgerson, B. M., Sager, M. A., Hermann, B. P., & Johnson, S. C. (2006). Reduced hippocampal activation during episodic encoding in middle-aged individuals at genetic risk of Alzheimer’s disease: a cross-sectional study. BMC Medicine, 4, 1. doi:10.1186/1741-7015-4-1.
133. Tucker-Drob, E. M., Reynolds, C. A., Finkel, D., & Pedersen, N. L. (2014). Shared and unique genetic and environmental influences on aging-related changes in multiple cognitive abilities. Developmental Psychology, 50, 152–166. doi:10.1037/a0032468.
134. Tunbridge, E. M., Harrison, P. J., & Weinberger, D. R. (2006). Catechol-o-methyltransferase, cognition, and psychosis: Val158Met and beyond. Biological Psychiatry, 60(2), 141–151. doi:10.1016/j.biopsych.2005.10.024.
135. Tunbridge, E. M., Weickert, C. S., Kleinman, J. E., Herman, M. M., Chen, J., Kolachana, B. S.,.. Weinberger, D. R. (2007). Catechol-o-methyltransferase enzyme activity and protein expression in human prefrontal cortex across the postnatal lifespan. Cerebral Cortex, 17(5), 1206–1212. doi:10.1093/cercor/bhl032.
136. Turkheimer, E. (2011). Still missing. Research in Human Development, 8, 227–241. doi:10.1080/15427609.2011.625321.
137. Tyler, W. J., Alonso, M., Bramham, C. R., & Pozzo-Miller, L. D. (2002). From acquisition to consolidation: on the role of brain-derived neurotrophic factor signaling in hippocampal-dependent learning. Learning and Memory, 9, 224–237. doi:10.1101/lm.51202.
138. Vincent, J. L., Snyder, A. Z., Fox, M. D., Shannon, B. J., Andrews, J. R., Raichle, M. E., & Buckner, R. L. (2006). Coherent spontaneous activity identifies a hippocampal-parietal memory network. Journal of Neurophysiology, 96(6), 3517–3531. doi:10.1152/jn.00048.2006.
139. Vogler, C., Gschwind, L., Coynel, D., Freytag, V., Milnik, A., …, Papassotiropoulos, A. (2014). Substantial SNP-based heritability estimates for working memory performance. Translational Psychiatry, 4, e438. doi:10.1038/tp.2014.81.
140. Volkow, N. D. (2000). Association between age-related decline in dopamine activity and impairment in frontal and cingulate matabolism. American Journal of Psychiatry, 157, 75–80.
141. Ward, A. M., Schultz, A. P., Huijbers, W., Van Dijk, K. R., Hedden, T., & Sperling, R. A. (2014). The parahippocampal gyrus links the default-mode cortical network with the medial temporal lobe memory system. Human Brain Mapping, 35(3), 1061–1073. doi:10.1002/hbm.22234.
142. Westlye, L. T., Reinvang, I., Rootwelt, H., & Espeseth, T. (2012). Effects of APOE on brain white matter microstructure in healthy adults. Neurology, 79, 1961–1969. doi:10.1212/WNL.0b013e3182735c9c.
143. Wilson, R. S., Barral, S., Lee, J. H., Leurgans, S. E., Foroud, T. M., Sweet, R. A., …, Bennett, D. A. (2011). Heritability of different forms of memory in the Late Onset Alzheimer’s Disease Family Study. Journal of Alzheimers Disease, 23(2), 249–255. doi:10.3233/JAD-2010-101515
144. Wisdom, N. M., Callahan, J. L., & Hawkins, K. A. (2011). The effects of apolipoprotein E on non-impaired cognitive functioning: a meta-analysis. Neurobiology of Aging, 32(1), 63–74. doi:10.1016/j.neurobiolaging.2009.02.003.
145. Witte, A. V., & Flöel, A. (2012). Effects of COMT polymorphisms on brain function and behavior in health and disease. Brain Research Bulletin, 88(5), 418–428. doi:10.1016/j.brainresbull.2011.11.012.
146. Xu, G., McLaren, D. G., Ries, M. L., Fitzgerald, M. E., Bendlin, B. B., Rowley, H. A., & Johnson, S. C. (2009). The influence of parental history of Alzheimer’s disease and apolipoprotein E epsilon4 on the BOLD signal during recognition memory. Brain: A Journal of Neurology, 132(Pt 2), 383–391. doi:10.1093/brain/awn254.